Rezultati - Steven D. Nathan

Refine Results
  1. 1
    IPF clinical trial design and endpoints

    IPF clinical trial design and endpoints od Steven D. Nathan, Keith C. Meyer

    Izdano 2014
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation

    Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation od Oksana A. Shlobin, Steven D. Nathan

    Izdano 2012
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis

    Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis od Abhimanyu Chandel, Jean Pastré, S. Valéry, Christopher S. King, Steven D. Nathan

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics

    Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics od Andrew F. Shorr, Donald L. Helman, D. B. Davies, Steven D. Nathan

    Izdano 2005
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis

    Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis od William M. Reichmann, Yanni Yu, Dendy Macaulay, Eric Q. Wu, Steven D. Nathan

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant

    Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant od Andrew F. Shorr, Jennifer L. Wainright, Cindy Cors, Christopher J. Lettieri, Steven D. Nathan

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis

    The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis od Christopher J. Lettieri, Steven D. Nathan, Robert Browning, Scott D. Barnett, Shahzad Ahmad, Andrew F. Shorr

    Izdano 2006
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    SERIAL MEASURES OF PULMONARY ARTERY PRESSURES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

    SERIAL MEASURES OF PULMONARY ARTERY PRESSURES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS od Steven D. Nathan, Shahzad Ahmad, James P. Koch, Scott D. Barnett, Niv Ad, Nelson A. Burton

    Izdano 2005
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Heart rate recovery after six‐minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis

    Heart rate recovery after six‐minute walk test predicts pulmonary hypertension in patients with idiopathic pulmonary fibrosis od Jeffrey J. Swigris, Amy L. Olson, Oksana A. Shlobin, Shahzad Ahmad, Kevin K. Brown, Steven D. Nathan

    Izdano 2010
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    The 6-min walk test as a primary end-point in interstitial lung disease

    The 6-min walk test as a primary end-point in interstitial lung disease od Sergio Harari, Athol U. Wells, Wim Wuyts, Steven D. Nathan, Klaus-Uwe Kirchgaessler, Monica Bengus, Jürgen Behr

    Izdano 2022
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis

    Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis od Stephanie Shin, Christopher S. King, Nitin Puri, Oksana A. Shlobin, Anne Brown, Shahzad Ahmad, Nargues Weir, Steven D. Nathan

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis

    Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis od Mark Fisher, Steven D. Nathan, Christian Hill, J.D. Marshall, F. Dejonckheere, Per-Olof Thuresson, Toby M. Maher

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views

    Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views od Toby M. Maher, Jeffrey J. Swigris, Michael Kreuter, Marlies Wijsenbeek, Nicola Cassidy, Lucy Ireland, Judit Axmann, Steven D. Nathan

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease

    Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease od Ho Cheol Kim, Abhimanyu Chandel, Christopher S. King, Min Jee Kim, Malek Shawabkeh, Ambalavanan Arunachalam, Rade Tomic, Steven D. Nathan

    Izdano 2025
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

    Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis od Steven D. Nathan, Ashwin Basavaraj, Cristina Reichner, Oksana A. Shlobin, Shahzad Ahmad, Joseph Kiernan, Nelson A. Burton, Scott D. Barnett

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Lung Transplantation for Patients With COVID-19

    Lung Transplantation for Patients With COVID-19 od Christopher S. King, Hannah Mannem, Jasleen Kukreja, Shambhu Aryal, Daniel Tang, Jonathan P. Singer, Ankit Bharat, Jürgen Behr, Steven D. Nathan

    Izdano 2021
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD

    The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD od Martin Kolb, Stylianos E. Orfanos, Christopher Lambers, Kevin R. Flaherty, Alison Masters, Lisa Lancaster, Adam M. Silverstein, Steven D. Nathan

    Izdano 2022
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD

    Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD od Steven D. Nathan, Abhimanyu Chandel, Ya Wang, Jiawei Xu, Lixin Shao, Timothy R. Watkins, Jack Diviney, Christopher S. King, Ling Han

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

    Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Inn... od Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John Scandurra, Paul M. Hassoun, Sylvia Nikkho, Steven D. Nathan

    Izdano 2024
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts

    Sustained Activation of Toll-Like Receptor 9 Induces an Invasive Phenotype in Lung Fibroblasts od Varvara Kirillov, Jonathan T. Siler, Mahalakshmi Ramadass, Lingyin Ge, James E. Davis, Geraldine M. Grant, Steven D. Nathan, Gábor Járai, Glenda Trujillo

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: